首页> 外文期刊>Nucleic Acids Research >Highly efficient 'hit-and-run' genome editing with unconcentrated lentivectors carrying Vpr.Prot.Cas9 protein produced from RRE-containing transcripts
【24h】

Highly efficient 'hit-and-run' genome editing with unconcentrated lentivectors carrying Vpr.Prot.Cas9 protein produced from RRE-containing transcripts

机译:高效的“击中和运行”基因组编辑,携带携带含RRE的转录物的VPR.prot.cas9蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

The application of gene-editing technology is currently limited by the lack of safe and efficient methods to deliver RNA-guided endonucleases to target cells. We engineered lentivirus-based nanoparticles to co-package the U6-sgRNA template and the CRISPR-associated protein 9 (Cas9) fused with a virion-targeted protein Vpr (Vpr.Prot.Cas9), for simultaneous delivery to cells. Equal spatiotemporal control of the vpr.prot.cas9 and gag/pol gene expression (the presence of Rev responsive element, RRE) greatly enhanced the encapsidation of the fusion protein and resulted in the production of highly efficient lentivector nanoparticles. Transduction of the unconcentrated, Vpr.Prot.Cas9-containing vectors led to >98% disruption of the EGFP gene in reporter HEK293-EGFP cells with minimal cytotoxicity. Furthermore, we detected indels in the targeted endogenous loci at frequencies of up to 100% in cell lines derived from lymphocytes and monocytes and up to 15% in primary CD4+ T cells by high-throughput sequencing. This approach may provide a platform for the efficient, dose-controlled and tissue-specific delivery of genome editing enzymes to cells and it may be suitable for simultaneous endogenous gene disruption and a transgene delivery.
机译:基因编辑技术的应用,目前由于缺乏安全,高效的方法来提供RNA指导的核酸内切酶的靶细胞的限制。我们设计与病毒体靶向蛋白Vpr基因(Vpr.Prot.Cas9),用于同时递送至细胞融合的基于慢病毒的纳米颗粒以共包的U6-因组模板和CRISPR相关蛋白9(Cas9)。的vpr.prot.cas9和gag / pol基因表达(Rev效应元件的存在,RRE)的等于时空控制大大提高了融合蛋白的衣壳化,并导致生产高效慢病毒载体的纳米颗粒。导致记者HEK293-EGFP细胞中的EGFP基因具有最小的细胞毒性的> 98%的破坏未浓缩的,含有Vpr.Prot.Cas9的载体的转导。此外,我们检测在目标内源基因座插入缺失以高达100%的通过高通量测序从淋巴细胞和单核细胞和高达15%的在原代CD4 + T细胞的细胞系的频率。这种方法可以提供用于基因组编辑酶细胞的有效的,剂量控制,并且组织特异性递送的平台,它可以是适合于同时进行内源基因破坏和转基因递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号